Liposome-Encapsulated Hemoglobin Reduces the Size of Cerebral Infarction in the Rat
Author(s) -
Akira T. Kawaguchi,
Dai Fukumoto,
Munetaka Haida,
Yoshitaka Ogata,
Mariko Yamano,
Hideo Tsukada
Publication year - 2007
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.106.467290
Subject(s) - medicine , extravasation , hemoglobin , infarction , anesthesia , saline , middle cerebral artery , cerebral infarction , liposome , blood substitute , thrombosis , cerebral cortex , pathology , ischemia , biochemistry , chemistry , myocardial infarction
Liposome-encapsulated hemoglobin (LEH; TRM-645) is a novel oxygen (O(2)) carrier with a lower O(2) affinity (P(50)O(2)=40 mm Hg) than red blood cells. In contrast to cell-free hemoglobin, encapsulation prevents hemoglobin extravasation, whereas its subcellular size (230 nm) may improve O(2) delivery and limit the severity of cerebral infarction.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom